Stock pick for 2021: Convatec
After recently upgrading (28 October) full-year revenue growth to the top of its 2% to 3.5% target range, medical products company ConvaTec (CTEC) looks well placed going into 2021 as several tailwinds form.
A faster than anticipated recovery in US elective surgeries is providing a boost for its wound care business and new product launches position the company for renewed ...